59 results for "Colla, Simona"
Showing 1–20 · 0.19 seconds · RSS
-
Journal Article Full text
Dysfunctional telomeres and hematological disorders
Telomere biology disorders, which are characterized by telomerase activity haploinsufficiency and accelerated telomere shortening, most commonly manifest as degenerative diseases. Tissues with high rates of cell turnover, such as those in the hematopoietic system, are particularly vulnerable to…
-
Journal Article Full text
RNA processing: a new player of genomic instability in multiple myeloma
-
Journal Article Full text
Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromes
Drug testing assays in hematopoietic stem and progenitor cells (HSPCs) are fundamental in biological studies of myelodysplastic syndromes (MDS) but have historically entailed a technical challenge. This protocol allows the efficient isolation of MDS HSPCs from bone marrow mononuclear cell fractions…
-
Journal Article Full text
Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation
Myelodysplastic syndromes (MDSs) are a heterogeneous group of clonal hematopoietic stem cell disorders characterized by myeloid dysplasia, peripheral blood cytopenias, and increased risk of progression to acute myeloid leukemia (AML). The standard of care for patients with MDS is hypomethylating…
-
Journal Article Full text
A machine learning-based method for automatically identifying novel cells in annotating single-cell RNA-seq data
MOTIVATION: Single-cell RNA sequencing (scRNA-seq) has been widely used to decompose complex tissues into functionally distinct cell types. The first and usually the most important step of scRNA-seq data analysis is to accurately annotate the cell labels. In recent years, many supervised annotation…
-
Journal Article Full text
CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27(Kip1)-dependent and -independent mechanisms
Overexpression of CKS1B, a gene mapping within a minimally amplified region between 153 to 154 Mb of chromosome 1q21, is linked to a poor prognosis in multiple myeloma (MM). CKS1B binds to and activates cyclin-dependent kinases and also interacts with SKP2 to promote the ubiquitination and…
-
Journal Article Full text
The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells
Multiple myeloma (MM) plasma cells, but not those from healthy donors and patients with monoclonal gammopathy of undetermined significance or other plasma cell dyscrasias involving the bone marrow, express the Wnt-signaling antagonist DKK1. We previously reported that secretion of DKK1 by MM cells…
-
Journal Article Full text
LKB1 regulates quiescence and metabolic homeostasis of hematopoietic stem cells
The capacity to fine-tune cellular bioenergetics with the demands of stem cell maintenance and regeneration is central to normal development and aging and to organismal survival during periods of acute stress. How energy metabolism and stem cell homeostatic processes are coordinated is not well…
-
Journal Article Full text
Analysis of Class I and II Histone Deacetylase Gene Expression in Human Leukemia
Histone deacetylase (HDAC) inhibitors are well-characterized anti-leukemia agents, and HDAC gene expression deregulation has been reported in various types of cancers. We sought to characterize HDAC gene expression patterns in several types of leukemia. To do so, we performed a systematic study of…
-
Journal Article Full text
Down-regulation of EZH2 expression in myelodysplastic syndromes
EZH2 genetic mutations are common in myelodysplastic syndrome (MDS), which implies that this gene has a pathophysiological role in the disease. To further characterize molecular alterations of EZH2, and their potential prognostic impact in MDS, we assessed EZH2 RNA expression in primary bone marrow…
-
Journal Article Full text
Constitutive expression of IL-12Rβ2 on human multiple myeloma cells delineates a novel therapeutic target
The interleukin-12 (IL-12) receptor (R) B2 gene acts as tumor suppressor in human acute and chronic B-cell leukemias/lymphomas and IL-12rb2–deficient mice develop spontaneously localized plasmacytomas. With this background, we investigated the role of IL-12Rβ2 in multiple myeloma (MM) pathogenesis…
-
Journal Article Full text
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trial
In myelodysplastic syndromes (MDS), the IL-1β pathway is upregulated, and previous studies using mouse models of founder MDS mutations demonstrated that it enhances hematopoietic stem and progenitor cells’ (HSPCs’) aberrant differentiation towards the myeloid lineage at the expense of…
-
Journal Article Full text
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice
KDM6B is an epigenetic regulator that mediates transcriptional activation during differentiation, including in bone marrow (BM) hematopoietic stem and progenitor cells (HSPCs). Overexpression of KDM6B has been reported in BM HSPCs of patients with myelodysplastic syndromes (MDS) and chronic…
-
Journal Article Full text
Activating somatic and germline TERT promoter variants in myeloid malignancies
-
Journal Article Full text
S185: TARGETING DNA2 OVERCOMES METABOLIC REPROGRAMMING IN 1Q21 MULTIPLE MYELOMA
-
Journal Article Full text
Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletion
-
Journal Article Full text
An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemia
Approximately 30% of patients with chronic myelomonocytic leukemia (CMML) undergo transformation to a chemo-refractory blastic phase (BP-CMML). Seeking novel therapeutic approaches, we profiled blast transcriptomes from 42 BP-CMMLs, observing extensive transcriptional heterogeneity and poor…
-
Journal Article Full text
Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells
BCL-X(L) and BCL-2 are key anti-apoptotic proteins and validated cancer targets. 753B is a novel BCL-X(L)/BCL-2 proteolysis targeting chimera (PROTAC) that targets both BCL-X(L) and BCL-2 to the von Hippel-Lindau (VHL) E3 ligase, leading to BCL-X(L)/BCL-2 ubiquitination and degradation selectively…
-
Journal Article Full text
Clinical and molecular features of immunodeficiency in patients with telomere biology disorders()()
Immunodeficiency in telomere biology disorders (TBDs) has been described in pediatric patients with severe phenotypes, but is less characterized within the broader TBD spectrum. We collected complete blood counts, lymphocyte subsets, and infection history from 88 consecutive patients with TBD with…
-
Journal Article Full text
The molecular classification of multiple myeloma
To better define the molecular basis of multiple myeloma (MM), we performed unsupervised hierarchic clustering of mRNA expression profiles in CD138-enriched plasma cells from 414 newly diagnosed patients who went on to receive high-dose therapy and tandem stem cell transplants. Seven disease…